Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Monopar Therapeutics Inc. Cash Flow Breakdown

Cash flow breakdown shows where Monopar Therapeutics Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $12.20M went out.
  • Fiscal year ended 2025-12-31: from investing, $63.45M went out.
  • Fiscal year ended 2025-12-31: from financing, $91.57M came in.
  • Fiscal year ended 2025-12-31: change in cash, $16.02M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$12.20M-$63.45M-$35.00M-$1.13M$0.00$127.71M*$16.02M
2024-12-31-$6.40M-$14.34M$0.00-$104.22K$4.20M$55.19M*$38.55M
2023-12-31-$7.86M$4.93M-$46.97K$2.07M-$920.11K
2022-12-31-$7.23M-$4.92M-$76.63K$109.34K-$12.12M
2021-12-31-$7.32M$0.00$17.48K$10.86M*$3.57M
2020-12-31-$4.66M$8.18M$3.52M
2019-12-31-$3.02M$0.00$9.35M*$6.32M
2018-12-31-$2.68M$0.00-$2.89M
2017-12-31-$2.63M$4.71M$4.83M*$6.91M
2016-12-31-$1.19M$0.00$1.26M*$67.87K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$3.25M*$4.12M*-$654.96K*$7.58K*
2026-03-31-$3.47M-$5.58M-$200.20K$0.00-$9.29M
2025-12-31-$3.37M*-$62.19M*$0.00*-$298.09K*$0.00*
2025-09-30-$2.09M*-$2.13M*-$381.56K*$0.00*$92.77M*
2025-06-30-$1.08M*$1.19M*-$321.56K*$4.71K*
2025-03-31-$5.66M-$325.83K-$131.13K$15.45K-$6.10M
2024-12-31-$2.00M*-$14.34M*$0.00*-$66.95K*$1.01M*$55.19M*
2024-09-30-$1.07M*$985.73K*-$16.53K*$0.00*
2024-06-30-$1.68M*-$2.42K*-$10.00K*-$1.00*
2024-03-31-$1.66M-$983.31K-$10.74K$3.19M$541.50K
2023-12-31-$1.55M*$2.97M*-$5.32K*$339.87K*
2023-09-30-$1.94M*-$13.05K*-$8.21K*$254.91K*
2023-06-30-$2.10M*$2.95M*-$16.61K*$657.79K*
2023-03-31-$2.27M-$983.44K-$16.83K$821.63K-$2.46M
2022-12-31-$1.30M*-$4.92M*-$19.64K*$109.34K*
2022-09-30-$2.15M*$0.00*-$10.67K*$0.00*
2022-06-30-$1.31M*$0.00*$41.00*
2022-03-31-$2.47M$0.00$0.00-$2.48M
2021-12-31-$2.03M*$0.00*
2021-09-30-$1.94M*$0.00*-$1.95M*
2021-06-30-$1.41M*$0.00*-$1.43M*
2021-03-31-$1.94M$10.93M$8.99M
2020-12-31-$1.24M*$0.00*-$1.25M*
2020-09-30-$1.30M*$6.75M*$5.44M*
2020-06-30-$995.47K*$913.52K*-$46.17K*
2020-03-31-$1.13M$508.04K-$621.57K
2019-12-31-$668.71K*$0.00*$9.39M*$8.72M*
2019-09-30-$613.27K*$0.00*-$635.29K*
2019-06-30-$739.74K*$0.00*-$751.24K*
2019-03-31-$995.97K$0.00-$1.01M
2018-12-31-$519.21K*$0.00*-$725.49K*
2018-09-30-$599.56K*$0.00*-$600.38K*
2018-06-30-$752.86K*$0.00*-$754.43K*
2018-03-31-$808.85K$0.00-$808.85K
2017-12-31-$816.02K*$10.00K*-$806.02K*
2017-09-30-$1.19M*$2.67M*$4.83M*$6.31M*
2017-06-30-$305.13K*$1.04M*$729.91K*
2017-03-31-$311.49K$990.00K$678.52K

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B